DAPA-HF: does dapagliflozin provide "bang for your buck" as a treatment for HFrEF?
File(s)
Author(s)
Cowie, Martin R
Type
Journal Article
Date Issued
2020-11
Date Acceptance
2020-08-15
Citation
European Journal of Heart Failure, 2020, 22 (11), pp.2157-2159
ISSN
1388-9842
Publisher
WIley
Start Page
2157
End Page
2159
Journal / Book Title
European Journal of Heart Failure
Volume
22
Issue
11
Copyright Statement
© 2020 Owner. This is the accepted version of the following article: Cowie, M.R. (2020), DAPA‐HF: does dapagliflozin provide “bang for your buck” as a treatment for HFrEF?. Eur J Heart Fail. Accepted Author Manuscript. doi:10.1002/ejhf.1982, which has been published in final form at https://doi.org/10.1002/ejhf.1982.
Sponsor
Imperial College Trust
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/32809240
Grant Number
N/A
Subjects
Science & Technology
Life Sciences & Biomedicine
Cardiac & Cardiovascular Systems
Cardiovascular System & Cardiology
COST-EFFECTIVENESS
HEART-FAILURE
Cardiovascular System & Hematology
1102 Cardiorespiratory Medicine and Haematology
Publication Status
Published
Coverage Spatial
England
Date Publish Online
2020-08-18